Cagent Vascular receives $9M investment to accelerate marketing of its lead product

The FDA granted marketing clearance last year for the company's product used to treat below-the-knee peripheral artery disease.

Source: bizjournals.com Health Care:Biotechnology headlines - June 21, 2021 Category: Biotechnology Authors: John George Source Type: news